BIOGROUP
BIOGROUP, a leading player in the French biotechnology sector, is headquartered in France and operates extensively across Europe. Founded in 2003, the company has established itself as a pioneer in the field of medical diagnostics and laboratory services, focusing on innovative solutions that enhance patient care. With a diverse portfolio that includes clinical biology, genetic testing, and specialised laboratory services, BIOGROUP stands out for its commitment to quality and precision. The company has achieved significant milestones, including the expansion of its laboratory network and the introduction of cutting-edge diagnostic technologies. Recognised for its excellence in the industry, BIOGROUP continues to strengthen its market position through strategic partnerships and a dedication to research and development, ensuring it remains at the forefront of the biotechnology landscape.
DitchCarbon Score
How does BIOGROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOGROUP's score of 24 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOGROUP's reported carbon emissions
In 2023, BIOGROUP has not disclosed specific carbon emissions data in kg CO2e. However, the company has set ambitious climate commitments, focusing on achieving net-zero emissions for Scope 1 and Scope 2 by 2025. This commitment reflects BIOGROUP's dedication to actively combat climate change and preserve the environment. In previous years, the company reported carbon intensity metrics, with a total carbon intensity of approximately 16.0 in 2021 and 14.0 in 2022, measured in counts, indicating a potential trend towards reducing emissions intensity. Additionally, the DASRI (Déchets d'Activités de Soins à Risques Infectieux) rates were reported at 0.17 in 2021 and 0.11 in 2022, suggesting ongoing efforts to manage waste-related emissions. BIOGROUP's near-term targets for 2023 to 2025 demonstrate a proactive approach to sustainability, although specific reduction percentages have not been disclosed. The company is committed to transparency and continuous improvement in its environmental performance, aligning with industry standards for climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BIOGROUP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
